Deciphera Pharmaceuticals Inc (NASDAQ:DCPH)
| 69.40 Delayed Data As of Jan 17 |  +2.23 / +3.32%Today’s Change | 19.88 Today|||52-Week Range 70.00 | +11.50% Year-to-Date |
Latest DCPH News | Press Releases
No recent news for Deciphera Pharmaceuticals Inc.
Today’s Trading
| Previous close | 67.17 |
| Today’s open | 67.00 |
| Day’s range | 66.90 - 69.88 |
| Volume | 438,887 |
| Average volume (3 months) | 540,464 |
| Market cap | $3.3B |
Data as of 4:00pm ET, 01/17/2020
Growth & Valuation
| Earnings growth (last year) | +5.64% |
| Earnings growth (this year) | -51.08% |
| Earnings growth (next 5 years) | +21.46% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 9.34 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MNTAMomenta Pharmaceutic... | +0.53 | +1.76% |
| ZLABZai Lab Ltd | +1.44 | +2.79% |
| CRSPCRISPR Therapeutics ... | -1.30 | -2.18% |
| AXSMAxsome Therapeutics ... | -2.14 | -2.31% |
Data as of 4:00pm ET, 01/17/2020
Financials
| Next reporting date | March 25, 2020 |
| EPS forecast (this quarter) | -$1.16 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$99.9M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Waltham, Massachusetts |
Forecasts
